EIDD-1931 (NHC)
Product Specifications
CAS Number
3258-02-4
Synonyms
Beta-d-N4-hydroxycytidine
Target
SARS-CoV
Applications
Microbiology
Smiles
OCC1OC (C (O) C1O) N2C=C\C (NC2=O) =N\O
Molecular Formula
C9H13N3O6
Additionnal Information
EIDD-1931 (NHC) is an active metabolite of EIDD-2801, a promising COVID-19 inhibitor. EIDD-1931 (NHC) has broad spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c Bat-CoVs with average IC50 of 0.15 μM, as well as increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivir.
Storage Conditions
3 years -20°C powder
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15293480 1 Vial
Lentiviral mouse Obox5 shRNA (UAS) - Lentiviral mouse Obox5 shRNA (UAS) (25)
Sign In for Pricing
View Details 
IGBOBSCZ 1 Each
Innovative Grade US Origin Bovine Bone Scapula Frozen
Sign In for Pricing
View Details 
YA944033-01 50 µg
Anti-phOx/2-phenyloxazol-5 (4H) -one Antibody (20G9)
Sign In for Pricing
View Details YA944033-02 100 µg
Anti-phOx/2-phenyloxazol-5 (4H) -one Antibody (20G9)
Sign In for Pricing
View Details YA944033-03 1 mg
Anti-phOx/2-phenyloxazol-5 (4H) -one Antibody (20G9)
Sign In for Pricing
View Details